Quest PharmaTech Inc.
QPT.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.40K | 525.50K | -634.80K | 10.73M | -559.70K |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.20K | -606.40K | 599.50K | -10.89M | 448.00K |
| Change in Net Operating Assets | -28.10K | -53.90K | -120.20K | 114.30K | 106.20K |
| Cash from Operations | -98.90K | -134.80K | -155.50K | -45.70K | -5.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 684.70K | -- |
| Cash from Financing | -- | -- | -- | 507.20K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.90K | -134.80K | -155.50K | 461.40K | -5.50K |